Yinkang-008

N/A

Report date: 2025/01/26 15:46:28

NME

Base Information

Drug NameYinkang-008

Drug Alias NameTIGIT checkpoint inhibitor (Ajud Biopharma)T cell immunoreceptor Ig ITIM protein inhibitor (Yinkang Biopharma)TIGIT checkpoint inhibitor (Yinkang Biopharma)AJUD-008

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionT cell immunoglobulin and ITIM domains inhibitors

TargetsT cell immunoglobulin and ITIM domains

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesYinkang Biopharma Inc.

China Registration ClassN/A

Develop Information

Active CompaniesYinkang Biopharma Inc.

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A